Regulatory News
Wednesday, May 4, 2016
BRIEF-OncBioMune submits protocol for two phase 2 clinical trials
* OncBioMune submits protocol to principal investigators for
two phase 2 clinical trials of proscavax for prostate cancer
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom:...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment